Published in Endocrinology on July 26, 2007
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov (2009) 3.26
Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34. Surg Endosc (2008) 1.95
Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol Psychiatry (2009) 1.87
Circadian system, sleep and endocrinology. Mol Cell Endocrinol (2011) 1.38
Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression. Addict Biol (2011) 1.28
Central nervous system regulation of energy metabolism: ghrelin versus leptin. Ann N Y Acad Sci (2008) 1.20
Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics. Pharmacol Ther (2008) 1.16
Brain regulation of appetite and satiety. Endocrinol Metab Clin North Am (2008) 1.15
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol (2009) 1.06
The role of ghrelin in reward-based eating. Biol Psychiatry (2012) 1.03
Obesity treatment: novel peripheral targets. Br J Clin Pharmacol (2009) 0.95
Minireview: Gut peptides: targets for antiobesity drug development? Endocrinology (2009) 0.94
Ghrelin attenuates cAMP-PKA signaling to evoke insulinostatic cascade in islet β-cells. Diabetes (2011) 0.94
Ghrelin in the CNS: from hunger to a rewarding and memorable meal? Brain Res Rev (2008) 0.93
Disruption of cue-potentiated feeding in mice with blocked ghrelin signaling. Physiol Behav (2012) 0.93
Ghrelin's second life: from appetite stimulator to glucose regulator. World J Gastroenterol (2012) 0.93
Functionally biased signalling properties of 7TM receptors - opportunities for drug development for the ghrelin receptor. Br J Pharmacol (2013) 0.92
The effect of ghrelin on water intake during dipsogenic conditions. Physiol Behav (2008) 0.90
Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice. Proc Natl Acad Sci U S A (2008) 0.90
The impact of sleep and circadian disturbance on hormones and metabolism. Int J Endocrinol (2015) 0.90
The β-cell GHSR and downstream cAMP/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelin. Sci Rep (2015) 0.89
Appetite regulation and weight control: the role of gut hormones. Nutr Diabetes (2012) 0.88
Integrating GHS into the Ghrelin System. Int J Pept (2010) 0.88
Effect of ghrelin on glucose-insulin homeostasis: therapeutic implications. Int J Pept (2010) 0.88
Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis. Nat Rev Gastroenterol Hepatol (2012) 0.87
The ghrelin axis in disease: potential therapeutic indications. Mol Cell Endocrinol (2011) 0.87
Ghrelin in diabetes and metabolic syndrome. Int J Pept (2010) 0.87
Characterization of the insulin sensitivity of ghrelin receptor KO mice using glycemic clamps. BMC Physiol (2011) 0.86
G Protein and β-arrestin signaling bias at the ghrelin receptor. J Biol Chem (2014) 0.85
Oligoclonal antibody targeting ghrelin increases energy expenditure and reduces food intake in fasted mice. Mol Pharm (2011) 0.84
Nutritional state-dependent ghrelin activation of vasopressin neurons via retrograde trans-neuronal-glial stimulation of excitatory GABA circuits. J Neurosci (2014) 0.83
Altered ghrelin secretion in mice in response to diet-induced obesity and Roux-en-Y gastric bypass. Mol Metab (2014) 0.82
Can Bayliss and Starling gut hormones cure a worldwide pandemic? J Physiol (2014) 0.81
Role of SST, CORT and ghrelin and its receptors at the endocrine pancreas. Front Endocrinol (Lausanne) (2012) 0.80
Actions of Agonists and Antagonists of the ghrelin/GHS-R Pathway on GH Secretion, Appetite, and cFos Activity. Front Endocrinol (Lausanne) (2013) 0.80
Immunization against active ghrelin using virus-like particles for obesity treatment. Curr Pharm Des (2013) 0.80
Ghrelin-related peptides exert protective effects in the cerebral circulation of male mice through a nonclassical ghrelin receptor(s). Endocrinology (2015) 0.79
Assessing the role of the growth hormone secretagogue receptor in motivational learning and food intake. Behav Neurosci (2009) 0.78
Obesity pharmacotherapy: current perspectives and future directions. Curr Cardiol Rev (2013) 0.77
The hungry stomach: physiology, disease, and drug development opportunities. Front Pharmacol (2011) 0.76
Hypotensive effects of ghrelin receptor agonists mediated through a novel receptor. Br J Pharmacol (2014) 0.76
Antagonism of ghrelin for glycemic control in type 2 diabetes mellitus? Endocrinology (2007) 0.76
From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation. Int J Mol Sci (2017) 0.76
Obesity vaccines. Hum Vaccin Immunother (2013) 0.75
Growth hormone secretagogue receptor deficiency in mice protects against obesity-induced hypertension. Physiol Rep (2014) 0.75
Recent advances in potential clinical application of ghrelin in obesity. J Obes (2012) 0.75
Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options. Pharmaceuticals (Basel) (2010) 0.75
Ghrelin's control of food reward and body weight in the lateral hypothalamic area is sexually dimorphic. Physiol Behav (2017) 0.75
Therapeutic Potential of Targeting the Ghrelin Pathway. Int J Mol Sci (2017) 0.75
Development of Fluorinated Non-Peptidic Ghrelin Receptor Ligands for Potential Use in Molecular Imaging. Int J Mol Sci (2017) 0.75
Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy. Immunotargets Ther (2015) 0.75
Ghrelin receptor antagonism of hyperlocomotion in cocaine-sensitized mice requires βarrestin-2. Synapse (2017) 0.75
Evidence that central pathways that mediate defecation utilize ghrelin receptors but do not require endogenous ghrelin. Physiol Rep (2017) 0.75
Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci U S A (2003) 3.21
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity. Proc Natl Acad Sci U S A (2012) 3.21
A polymeric protein anchors the chromosomal origin/ParB complex at a bacterial cell pole. Cell (2008) 3.15
Transgenic plants expressing two Bacillus thuringiensis toxins delay insect resistance evolution. Nat Biotechnol (2003) 2.80
Upstream migration of Xylella fastidiosa via pilus-driven twitching motility. J Bacteriol (2005) 2.11
The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. Ann Rheum Dis (2013) 2.10
P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma. J Natl Cancer Inst (2013) 1.68
Clinicopathologic and prognostic characteristics of triple-negative breast cancer. Onkologie (2008) 1.65
Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activities. J Biol Chem (2003) 1.54
A proteome chip approach reveals new DNA damage recognition activities in Escherichia coli. Nat Methods (2007) 1.54
Spatial separation of photogenerated electrons and holes among {010} and {110} crystal facets of BiVO4. Nat Commun (2013) 1.50
A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer (2010) 1.46
Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe (2011) 1.43
Stretchable nanoparticle conductors with self-organized conductive pathways. Nature (2013) 1.42
Severe Alzheimer's disease: treatment effects on function and care requirements. J Am Med Dir Assoc (2010) 1.40
Mesoporous titania spheres with tunable chamber stucture and enhanced photocatalytic activity. J Am Chem Soc (2007) 1.39
Bioavailability of Sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prev Res (Phila) (2011) 1.37
Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer (2006) 1.35
AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors. Oncologist (2013) 1.29
Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice. J Lipid Res (2009) 1.27
Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus. J Med Chem (2012) 1.19
Assessing adhesion forces of type I and type IV pili of Xylella fastidiosa bacteria by use of a microfluidic flow chamber. Appl Environ Microbiol (2007) 1.19
Functional dissection of a HECT ubiquitin E3 ligase. Mol Cell Proteomics (2007) 1.17
Mesoporous Au/TiO2 nanocomposites with enhanced photocatalytic activity. J Am Chem Soc (2007) 1.15
Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade. Proc Natl Acad Sci U S A (2008) 1.12
Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer. DNA Cell Biol (2010) 1.09
Surgical treatment of a giant symptomatic cardiac lipoma. J Thorac Oncol (2013) 1.08
LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse. J Lipid Res (2009) 1.08
Ras inhibition via direct Ras binding--is there a path forward? Bioorg Med Chem Lett (2012) 1.08
Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population. PLoS One (2013) 1.07
p21-Activated kinase inhibitors: a patent review. Expert Opin Ther Pat (2012) 1.07
Percutaneous closure of a post-traumatic ventricular septal defect with a patent ductus arteriosus occluder. Clinics (Sao Paulo) (2012) 1.07
Analysis of genetic diversity in Ganoderma population with a novel molecular marker SRAP. Appl Microbiol Biotechnol (2006) 1.07
Promoter- and strain-selective enhancement of gene expression in a mouse skeletal muscle by a polymer excipient Pluronic P85. J Control Release (2005) 1.04
Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells. World J Gastroenterol (2007) 1.03
A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes. Diabetes (2002) 1.02
MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol (2013) 1.02
Total synthesis of the nematicidal cyclododecapeptide omphalotin A by using racemization-free triphosgene-mediated couplings in the solid phase. Angew Chem Int Ed Engl (2002) 1.01
Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. J Virol (2005) 1.01
A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia. Am J Physiol Gastrointest Liver Physiol (2009) 1.01
Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line. Oncogene (2003) 1.01
Specific inhibition of hormone-sensitive lipase improves lipid profile while reducing plasma glucose. J Pharmacol Exp Ther (2005) 0.99
Shape-morphing nanocomposite origami. Langmuir (2014) 0.99
Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity. J Med Chem (2007) 0.99
[A thirty-one year prospective follow-up program on the HBsAg carrier state and primary liver cancer in Qidong, China]. Zhonghua Liu Xing Bing Xue Za Zhi (2010) 0.98
A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. J Virol (2012) 0.98
Rearranging exosites in noncatalytic domains can redirect the substrate specificity of ADAMTS proteases. J Biol Chem (2012) 0.97
Total parathyroidectomy with trace amounts of parathyroid tissue autotransplantation as the treatment of choice for secondary hyperparathyroidism: a single-center experience. BMC Surg (2014) 0.97
Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties. J Med Chem (2012) 0.96
Effect of exenatide on inflammatory and oxidative stress markers in patients with type 2 diabetes mellitus. Diabetes Technol Ther (2011) 0.95
Microwave-induced synthesis of porous single-crystal-like TiO2 with excellent lithium storage properties. Langmuir (2012) 0.95
Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines. J Med Chem (2003) 0.95
The role of VEGF/VEGFR2 signaling in peripheral stimulation-induced cerebral neurovascular regeneration after ischemic stroke in mice. Exp Brain Res (2011) 0.94
The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model. J Pharmacol Exp Ther (2009) 0.94
The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes. Clin Chim Acta (2004) 0.94
Effects of three auxin-inducible LBD members on lateral root formation in Arabidopsis thaliana. Planta (2012) 0.93
Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray. J Infect Dis (2011) 0.93
Design of a long acting peptide functioning as both a glucagon-like peptide-1 receptor agonist and a glucagon receptor antagonist. J Biol Chem (2006) 0.93
Neuroprotective effects of resveratrol on ischemic injury mediated by improving brain energy metabolism and alleviating oxidative stress in rats. Neuropharmacology (2010) 0.92
CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer. Hum Immunol (2010) 0.92
Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study. Arthritis Res Ther (2012) 0.92
Transplantation of MSCs in combination with netrin-1 improves neoangiogenesis in a rat model of hind limb ischemia. J Surg Res (2009) 0.92
Transparent conductors from layer-by-layer assembled SWNT films: importance of mechanical properties and a new figure of merit. ACS Nano (2010) 0.91
Pluronic Block Copolymers for Gene Delivery. Adv Genet (2005) 0.91
Single-crystal-like titania mesocages. Angew Chem Int Ed Engl (2010) 0.91
Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population. PLoS One (2012) 0.91
Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review. Clin Rheumatol (2010) 0.90
A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents. J Pharmacol Exp Ther (2007) 0.90
Back pocket flexibility provides group II p21-activated kinase (PAK) selectivity for type I 1/2 kinase inhibitors. J Med Chem (2014) 0.90
[Evaluation of secular trend of liver cancer incidence in Qidong, Jiangsu province, 1973-2002]. Zhonghua Yi Xue Za Zhi (2005) 0.90
PDE-10A inhibitors as insulin secretagogues. Bioorg Med Chem Lett (2007) 0.90
Chromosome 11q13.3 variant modifies renal cell cancer risk in a Chinese population. Mutagenesis (2011) 0.89
In situ encapsulation of Au nanoparticles in mesoporous core-shell TiO(2) microspheres with enhanced activity and durability. Chem Commun (Camb) (2009) 0.88
Multiparameter structural optimization of single-walled carbon nanotube composites: toward record strength, stiffness, and toughness. ACS Nano (2009) 0.88
LBD29 regulates the cell cycle progression in response to auxin during lateral root formation in Arabidopsis thaliana. Ann Bot (2012) 0.88
Phosphorylation of the chromatin binding domain of KSHV LANA. PLoS Pathog (2012) 0.88
Supercritical preparation of a highly active S-doped TiO2 photocatalyst for methylene blue mineralization. Environ Sci Technol (2007) 0.88
Variant allele of CHEK2 is associated with a decreased risk of esophageal cancer lymph node metastasis in a Chinese population. Mol Biol Rep (2011) 0.88
One-year open-label trial of thalidomide in ankylosing spondylitis. Arthritis Rheum (2002) 0.87
Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population. Prostate (2011) 0.87
Pluronic block copolymers for gene delivery. Adv Genet (2005) 0.87
The variant interleukin 1f7 rs3811047 G>A was associated with a decreased risk of gastric cardiac adenocarcinoma in a Chinese Han population. Tumour Biol (2013) 0.87
The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis. Mutagenesis (2011) 0.87
Arabidopsis ASL11/LBD15 is involved in shoot apical meristem development and regulates WUS expression. Planta (2013) 0.87
Twitching motility among pathogenic Xylella fastidiosa isolates and the influence of bovine serum albumin on twitching-dependent colony fringe morphology. FEMS Microbiol Lett (2007) 0.87